Clinical Trial Update: Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial results for the fixed-dose combination of telmisartan and amlodipine in severe hypertension have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• Telmisartan (Telmisartan)
• Twynsta (telmisartan/amlodipine) (telmisartan/amlodipine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-01-04